Skip to content

AtriClip® LAA Exclusion System PRO245 (REF A000967)Recalls & reported problems

Atricure, Inc. · AtriClip® PRO2 Gillinov-Cosgrove LAA Exclusion System 45 · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818354015058), received between Aug 11, 2022 and Aug 11, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Use of Device Problem1

Patient problems

  • Cardiac Perforation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 11, 2022Use of Device Problem; Use of Device Problem

    ON (B)(6) 2022 A 65-YEAR-OLD MALE PATIENT UNDERWENT A STAND ALONE ROBOTIC LEFT ATRIAL APPENDAGE (LAA) EXCLUSION PROCEDURE. THE PRO245 CLIP WAS PLACED AND CLOSURE OF THE LAA WAS CONFIRMED. AS THE SURGEON WAS PULLING THE APPLICATOR BACK, BLEEDING WAS OBSERVED. THE PROCEDURE WAS CONVERTED TO A STERNOTOMY AND A PERFORATION WAS DISCOVERED OF A CARDIAC VEIN THAT WAS MEDIAL TO THE BASE OF THE LAA. THE PERFORATION WAS REPAIRED WITH A 4-0 PROLENE SUTURE. THERE WAS NO REPORTED DEVICE MALFUNCTION, AND THE ADVERSE EVENT WAS THE RESULT OF A PROCEDURAL COMPLICATION.

    Patient problems: Cardiac Perforation

    MAUDE report 15209733 ↗

Other Clip, Implantable devices

All Clip, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page